Geron GERN
NASDAQ GERN
$1.52 -0.03 (-1.94%)
At close: Aug 21, 2026 · 4:00 PM EDT

Geron (GERN) Cash from Financing Activities (2010 - 2026)

Geron (GERN) posted Cash from Financing Activities of $2.4 million for Q1 2026, up 541.53% sequentially from $378000.0 in Q4 2025, and up 847.27% YoY from $256000.0 in Q1 2025.

Geron (GERN) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Geron has reported Cash from Financing Activities for 17 years, with the latest figure at $2.4 million in Q1 2026.

  • Quarterly Cash from Financing Activities rose 847.27% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 million (down 97.63% YoY) and the FY2025 annual result came in at $2.3 million, down 99.32% from the prior year.
  • Cash from Financing Activities rose to $2.4 million in Q1 2026 per GERN's latest filing, from $378000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $281.0 million in Q1 2023 and troughed at $256000.0 in Q1 2025.
  • A 5-year average of $47.9 million and a median of $11.9 million in 2022 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2025 and 2026: Cash from Financing Activities sank 99.83% in 2025, then jumped 847.27% in 2026.
  • Over 5 years, Cash from Financing Activities stood at $11.9 million in 2022, then soared by 179.12% to $33.3 million in 2023, then surged by 399.29% to $166.2 million in 2024, then tumbled by 99.77% to $378000.0 in 2025, then jumped by 541.53% to $2.4 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $2.4 million, $378000.0, and $542000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -426.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -1.22 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 14.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -6.05 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 36.24 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -16.65 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 27.18 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -273.15 Mn
10 Geron 1.02 Mn -299.83 Mn - 1.38 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.38 Mn
Jun 30, 2026 1.38 Mn
Mar 31, 2026 2.43 Mn
Mar 31, 2026 2.43 Mn
Dec 31, 2025 378,000.00
Dec 31, 2025 378,000.00
Sep 30, 2025 542,000.00
Sep 30, 2025 542,000.00
Jun 30, 2025 1.09 Mn
Jun 30, 2025 1.09 Mn
Mar 31, 2025 256,000.00
Mar 31, 2025 256,000.00
Dec 31, 2024 166.16 Mn
Dec 31, 2024 166.16 Mn
Sep 30, 2024 3.58 Mn
Sep 30, 2024 3.58 Mn
Jun 30, 2024 16.83 Mn
Jun 30, 2024 16.83 Mn
Mar 31, 2024 147.80 Mn
Mar 31, 2024 147.80 Mn